Header Logo

Connection

Michael Jelinek to Drug Resistance, Neoplasm

This is a "connection" page, showing publications Michael Jelinek has written about Drug Resistance, Neoplasm.
Connection Strength

0.162
  1. Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy. Clin Lung Cancer. 2019 11; 20(6):e597-e600.
    View in: PubMed
    Score: 0.162
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.